7 completed, 4 unknown, 3 active not recruiting, 3 recruiting. 23 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Completed 7, Unknown 4, Active not recruiting 3, Recruiting 3, Terminated 3, Withdrawn 2, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Oligodendroglioma: new trials by email Literature Review of Oligodendroglioma trials Research Report on Oligodendroglioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma Safusidenib, Placebo - Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation, Astrocytoma IDH Mutant Grade 2 | Phase 3 | Not yet recruiting | Nuvation Bio Inc. | 140 | 2027-03-01 | 2026-07-17 |
| SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) safusidenib, Placebo - Glioma, Astrocytoma, Grade IV | Phase 3 | Recruiting | Nuvation Bio Inc. | 365 | 2023-06-05 | 2026-10-19 |
| A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery PCV chemotherapy, Radiotherapy and PCV chemotherapy - Oligodendroglioma, Low-grade Oligodendroglioma | Phase 3 | Recruiting | Hospices Civils de Lyon | 280 | 2021-12-07 | 2026-01-29 |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). CETEG, PCV, RT - Oligodendroglioma | Phase 3 | Recruiting | University Hospital Heidelberg | 406 | 2021-04-07 | 2026-02-03 |
| Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma Extended Release Flucytosine, NovoTTF-100A Device, Quality-of-Life Assessment - Anaplastic Astrocytoma, Glioblastoma | Phase 2 / Phase 3 | Withdrawn | NRG Oncology | 2020-01-31 | 2026-05-07 | |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma Carmustine, tumor resection surgery - Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 3 | Unknown | Shandong Lanjin Pharmaceuticals Co.,Ltd | 236 | 2012-08-01 | 2012-08-03 |
| Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma Radiotherapy, Temozolomide - Astrocytoma, Oligodendroglioma | Phase 3 | Unknown | Sun Yat-sen University | 290 | 2012-07-01 | 2020-05-28 |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer cyproheptadine hydrochloride, placebo - Cancer | Phase 3 | Terminated | University of South Florida | 22 | 2010-06-01 | 2015-07-02 |
| Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma temozolomide, 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy - Brain and Central Nervous System Tumors, Neurotoxicity | Phase 3 | Active not recruiting | Eastern Cooperative Oncology Group | 540 | 2009-11-17 | 2026-10-05 |
| Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma concomitant temozolomide (TMZ), radiotherapy, procarbazine - Brain and Central Nervous System Tumors | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 305 | 2009-09-01 | 2026-01-22 |
| Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease | Phase 3 | Completed | Wake Forest University Health Sciences | 198 | 2008-02-01 | 2021-10-20 |
| Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) temozolomide, DNA methylation analysis, laboratory biomarker analysis - Brain and Central Nervous System Tumors | Phase 3 | Active not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 751 | 2007-12-01 | 2023-09-11 |
| Treatment Strategy for Low-grade Gliomas Radiation therapy, Temozolomide - Astrocytomas, Oligodendrogliomas | Phase 3 | Terminated | Sun Yat-sen University | 500 | 2007-12-01 | 2014-08-05 |
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Radiation Therapy or Temozolomide in Treating Patients With Gliomas temozolomide, radiation therapy - Brain and Central Nervous System Tumors | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 709 | 2005-07-01 | 2016-10-12 |
| Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors carboplatin, cisplatin, cyclophosphamide - Brain and Central Nervous System Tumors | Phase 3 | Unknown | Children's Hospital Los Angeles | 120 | 2004-03-01 | 2013-12-18 |
| Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors methylphenidate hydrochloride, quality-of-life assessment, radiation therapy - Brain and Central Nervous System Tumors, Cognitive/Functional Effects | Phase 3 | Terminated | Wake Forest University Health Sciences | 2002-04-01 | 2021-09-09 | |
| Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide Temozolomide, Focal radiotherapy - Anaplastic Astrocytoma, Oligodendroglioma | Phase 3 | Completed | Neuro-Oncology Working Group of the German Cancer Society | 318 | 1999-06-01 | 2008-07-17 |
| Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma lomustine, procarbazine hydrochloride, vincristine sulfate - Brain and Central Nervous System Tumors | Phase 2 / Phase 3 | Completed | Radiation Therapy Oncology Group | 370 | 1998-10-01 | 2024-07-09 |
| Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma carboplatin, vincristine sulfate, conventional surgery - Brain and Central Nervous System Tumors | Phase 3 | Unknown | Societe Internationale d'Oncologie Pediatrique | 200 | 1997-01-01 | 2013-12-04 |
Showing 20 of 23. Sign in to see all of them.
Astrocytoma (18) · Central Nervous System Neoplasms (11) · Glioma (10) · Glioblastoma (8) · Brain Neoplasms (6) · Choroid Plexus Neoplasms (4) · Gliosarcoma (4) · Ependymoma (3) · Glioma, Subependymal (3) · Medulloblastoma (3) · Meningioma (3) · Neuroectodermal Tumors, Primitive (3) · Chondrosarcoma (2) · Craniopharyngioma (2)
Neoplasms by Histologic Type (23) · Neoplasms, Germ Cell and Embryonal (23) · Neoplasms, Glandular and Epithelial (23) · Neoplasms, Nerve Tissue (23) · Neuroectodermal Tumors (23) · Neoplasms, Neuroepithelial (22) · Neoplasms (21) · Neoplasms by Site (14) · Nervous System Diseases (14) · Nervous System Neoplasms (14) · Glioma (13) · Brain Diseases (8) · Central Nervous System Diseases (8) · Cerebral Ventricle Neoplasms (4) · Neoplasms, Vascular Tissue (4)
Radiotherapy (14) · Temozolomide (9) · Vincristine (7) · Procarbazine (6) · Lomustine (5) · Carboplatin (2) · Carmustine (1) · Chemotherapy, Adjuvant (1) · Cisplatin (1) · Cyclophosphamide (1) · Cyproheptadine (1) · DNA (1) · DNA Methylation (1) · Donepezil (1) · Etoposide (1)
European Organisation for Research and Treatment of Cancer - EORTC (3) · Nuvation Bio Inc. (2) · Radiation Therapy Oncology Group (2) · Sun Yat-sen University (2) · Wake Forest University Health Sciences (2) · Alliance for Clinical Trials in Oncology (1) · Children's Hospital Los Angeles (1) · Eastern Cooperative Oncology Group (1) · Hospices Civils de Lyon (1) · INSYS Therapeutics Inc (1) · M.D. Anderson Cancer Center (1) · NRG Oncology (1) · Neuro-Oncology Working Group of the German Cancer Society (1) · Shandong Lanjin Pharmaceuticals Co.,Ltd (1) · Societe Internationale d'Oncologie Pediatrique (1)
United States (10) · Germany (6) · France (5) · Australia (4) · Belgium (4) · Canada (4) · China (4) · Italy (4) · Netherlands (4) · Switzerland (4) · United Kingdom (4) · Austria (3) · Hungary (2) · Israel (2) · New Zealand (2)
Edward G. Shaw, MD (2) · Anna Nowak, MD (1) · Brigitta Baumert, MD, PhD (1) · David A. Walker (1) · David Schiff, MD (1) · Geoffrey R. Barger, MD (1) · Girish Dhall, MD (1) · J. Gregory Cairncross, MD (1) · Jan C. Buckner, MD (1) · Jeffrey P. Krischer, PhD (1) · Jonathan L. Finlay, MB, ChB (1) · Karen L. Fink, MD, PhD (1) · Kelley Haley, RN, BSN (1) · Kurt A. Jaeckle, MD (1) · Kurt Jaeckle, MD (1)
PMID 35731991, PMID 11586105, PMID 16782910, PMID 16782911, PMID 17549014, PMID 18089866, PMID 18089867, PMID 18371182, PMID 18976072, PMID 19224764, PMID 19783377, PMID 19901104, PMID 20160062, PMID 20820870, PMID 21246521, PMID 21914791, PMID 22480131, PMID 22851558, PMID 23071237, PMID 23071247, PMID 23269986, PMID 24419119, PMID 27020837, PMID 27050206, PMID 27370396, PMID 27686943, PMID 27686946, PMID 28801186, PMID 29393183, PMID 29571083, PMID 31386061, PMID 32706640, PMID 34000245, PMID 35275197, PMID 35692047, PMID 41449147
2004 (1), 2018 (1), P30CA016672 (1), U10CA081851 (1), U10CA081920 (1), U10CA180868 (1)